Family · Pharmaceutical analytical standards
Delamanid
A new-generation antituberculosis drug, authorised in Europe in 2014 for multidrug-resistant pulmonary tuberculosis, always in combination with other drugs. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It blocks the production of methoxy- and keto-mycolic acids, long waxy molecules that form the tough cell wall of the tuberculosis bacillus.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
